3300 Bee Cave Road
Austin, TX 78746
Full Time Employees: 28
|Mr. John Rodney Varner||Co-Founder, Chairman, Pres & CEO||886.97k||N/A||1957|
|Mr. Ryan M. Confer M.S.||Chief Financial Officer||606.57k||N/A||1982|
|Ms. Catherine M. Vaczy Esq.||Exec. VP, Gen. Counsel, Corp. Sec. & Chief Strategy Officer||704.93k||N/A||1961|
|Dr. Hemant Kumar C.P.M., EMBA, Ph.D.||Chief Manufacturing & Technology Officer||N/A||N/A||1963|
|Mr. David M. Schloss||Sr. VP of HR||N/A||N/A||N/A|
|Mr. Thomas C. Gallagher Esq.||Sr. VP of Intellectual Property & Licensing||N/A||N/A||N/A|
|Dr. William E. Gannon Jr.||Member of Clinical Advisory Board & VP of Regulatory Affairs||N/A||N/A||N/A|
|Dr. Mark S. Berger M.D.||Chief Medical Officer||N/A||N/A||1955|
|Dr. Jack A. Roth F.A.C.S., FACS, M.D.||Chairman of Scientific & Medical Advisory Board||N/A||N/A||N/A|
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes, and GPX-003 for the treatment of type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
Genprex, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.